2024-2025 Regular Session • New Jersey Legislature
S3388
Legislative Summary
Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
6/6/2024
Introduced in the Senate, Referred to Senate Commerce Committee
Senate
2/10/2025
Reported from Senate Committee, 2nd Reading
Senate
2/25/2025
Passed by the Senate (38-0)
Senate
2/25/2025
Received in the Assembly without Reference, 2nd Reading
General Assembly
2/27/2025
Substituted for A4391
General Assembly
2/27/2025
Passed Assembly (Passed Both Houses) (75-0-0)
General Assembly
4/22/2025
Approved P.L.2025, c.45.
General Assembly
Roll Call Votes
Assembly Floor: Substitute for A4391 (Voice Vote)
2/27/2025
0
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Assembly Floor: Third Reading - Final Passage
2/27/2025
75
Yea
0
Nay
5
Not Voting
0
Absent
Result: PASSED
Senate Floor: Third Reading - Final Passage
2/25/2025
38
Yea
0
Nay
2
Not Voting
0
Absent
Result: PASSED
Senate Commerce Committee: Reported Favorably
2/10/2025
5
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Passed(4/22/2025)
Chamber
General Assembly
Sponsors
Democrat: 12
Primary Sponsor
Troy Singleton
Democrat